Upload
raja-friska-yulanda
View
218
Download
0
Embed Size (px)
Citation preview
8/9/2019 Patogenesis-2
1/37
Viral Pathogenesis
8/9/2019 Patogenesis-2
2/37
Viral Pathogenesis
Viral pathogenesis is the process by which a viral infection
leads to disease.
Viral pathogenesis is an abnormal situation of no value tothe virus.
The majority of viral infections are subclinical. It is not in
the interest of the virus to severely harm or kill the host.
The consequences of viral infections depend on theinterplay between a number of viral and host factors.
8/9/2019 Patogenesis-2
3/37
PATOGENESIS PENYAKIT VIRUS
PRINSIP : Terjadi siklus replikasi virus dalam sel hospesRespon imunseluler SitopatologiKematian, hiperplasia, kanker, tidak
terjadi apa-apa
Infeksi Viruspenyakit virusabnormalitas struktur!fungsi"
#Subklinik : infeksi dengan gejala tidak nyata#Klinik : infeksi dengan gejala $ tanda
Virus patogenmampu menginfeksi $ menyebabkan penyakit
Strain virulen strain yang lebih sering menyebabkan penyakit dibandingkan
strain lain
EFEK SITOPATIK (ESP)VIRUS SEL HOSPES PEKA
8/9/2019 Patogenesis-2
4/37
utcome of Viral Infection
Acute Infection
! "ecovery with no residue effects
! "ecovery with residue effects e.g. acute viral encephalitis leading to
neurological sequelae.! #eath
! Proceed to chronic infection
Chronic Infection
! $ilent subclinical infection for life e.g. %&V' ()V
! * long silent period before disease e.g. +IV' $$P(' P&,
! "eactivation to cause acute disease e.g. herpes and shingles.
! %hronic disease with relapses and e-cerbations e.g. +)V' +%V.
! %ancers e.g. ()V' +T,V/' +PV' +)V' +%V' ++V0
8/9/2019 Patogenesis-2
5/37
1actors in Viral Pathogenesis (ffects of viral infection on cells 2%ellular
Pathogenesis3
(ntry into the +ost
%ourse of Infection 2Primary "eplication' $ystemic
$pread' $econdary "eplication3
%ell4Tissue Tropism
%ell4Tissue #amage
+ost Immune "esponse
Virus %learance or Persistence
8/9/2019 Patogenesis-2
6/37
%ellular Pathogenesis
%ells can respond to viral infections in 5 ways6 2/3 7o apparent change'283 #eath' and 253 Transformation
#irect cell damage and death from viral infection may result from
! diversion of the cell9s energy! shutoff of cell macromolecular synthesis
! competition of viral m"7* for cellular ribosomes
! competition of viral promoters and transcriptional enhancers for cellulartranscriptional factors such as "7* polymerases' and inhibition of theinterferon defense mechanisms.
Indirect cell damage can result from! integration of the viral genome
! induction of mutations in the host genome
! inflammation
! host immune response.
8/9/2019 Patogenesis-2
7/37
REPRODUKSI VIRUS DALAMBIAKAN SEL :
# Adanya ESP Polioy!li"i#$Va%i&!lla$ H!%'!# Si'l!$ H!%'!#oo#"!%$ Mo%*ili$ M+'#$In,l+!n-a$ D!n.+!$ E&/o0i%+#$
1o#a&2i!0i%+#$ 1y"o!.alo0i%+## Adanya /a*a"an !"a*oli#!
#!l Polioy!li"i#$ E&/o0i%+#$Ad!no0i%+# 1o#a&2i!0i%+#
# Adanya '!*!n"+2an/!a.l+"inin Vi%+# In,l+!n-a$Pa%o"i"i# !'id!i&a$ E&/o0i%+#$1o#a&2i!0i%+#
# Adanya '%o#!# /!ad#o%'#iVi%+# Pa%ain,l+!n-a
# Adanya '!%+*a/an o%,olo.i2 #!lVi%+# Sa%&oa Ro+#$ Siian
Vi%+# 34 (SV 34)
ESP (1YTOPATHI1 EFFE1T) :
# P!n..!*+n.an #'" *alon# Pla#oli#i## Pi2no#i## Ka%yo%!2#i## P!*!n"+2an #in#i"i+# P!*!n"+2an #!l %a2#a#a *!%in"i
*anya2 (M+l"in+&l!a"!d Gian" 1!llFo%a"ion)
# Va2+oli#a#i5P!*!n"+2an #!l *+#a
(Foay 1!ll Fo%a"ion)# N!2%o#i#5'!n.!%+"an# P!*!n"+2an *adan in2l+#i
(In&l+#ion Body Fo%a"ion)
8/9/2019 Patogenesis-2
8/37
TIPE ESP PADA SEL HOSPES
Bia2an S!l No%al Vi%+#
P!n..!*+n.an
Pla#oli#i#
Va2+oli#a#i5S!l *+#a
Pi2no#i#
Sin#i"i+5S!l %a2#a#a
Badan In2l+#i
Ka%yo%!2#i#
N!2%o#i#5!n.!%+"
8/9/2019 Patogenesis-2
9/37
Viral (ntry
Skin &ost viruses which infect via the skin require a breach in thephysical integrity of this effective barrier' e.g. cuts or abrasions. &anyviruses employ vectors' e.g. ticks' mosquitos or vampire bats to breachthe barrier.
Conjunctiva and other mucous membranes rather e-posed site andrelatively unprotected
Respiratory tract In contrast to skin' the respiratory tract and all othermucosal surfaces possess sophisticated immune defence mechanisms' aswell as nonspecific inhibitory mechanisms 2cilliated epithelium' mucussecretion' lower temperature3 which viruses must overcome.
Gastrointestinal tract a hostile environment: gastric acid' bile salts'etc. Viruses that spread by the ;I tract must be adapted to this hostileenvironment.
Genitourinary tract relatively less hostile than the above' but lessfrequently e-posed to e-traneous viruses 2
8/9/2019 Patogenesis-2
10/37
JALUR ASU! "IRUS #A$A #%RU!AA& 'U(U)
8/9/2019 Patogenesis-2
11/37
6ALUR UMUM INFEKSI VIRUS
6al+% Ma#+2 K!lo'o2 Vi%+# G!7ala lo2al 'ada "!'a" a#+2In,!2#i !ny!l+%+/ dan'!nya2i" o%.an 2/+#+#
Sal+%an P!%na'a#an Ad!no0i%+#
H!%'!#0i%+#
Po0i%+#
Pi2o%na0i%+#
To.a0i%+#
O%"iyo0i%+#
Pa%ayo0i%+#
1o%ona0i%+#
K!*anya2an S'!#i!#
E'#"!in Ba%%$H!%'!# #i'l!
8
Rino0i%+#
8
In,l+!n-a
Pa%ain,l+!n-a$ 0i%+# Sin#i"ial
'!%na'a#an
K!*anya2 S'!#i!#
8
Va%i&!lla
1a&a% ('+na/)
B!*!%a'a En"!%o0i%+#
R+*!la
8
Gondon.$ 1a'a2
8
M+l+" dan Sal+%an U#+# Ad!no0i%+#
H!%'!#0i%+#
Pi2o%na0i%+#
R!o0i%+#
B!*!%a'a #'!#i!#
E'#"!in Ba%%$H!%'!#i'l!
8
Ro"a0i%+#
8
1y"o!.alo0i%+#
B*%' En"!%o0i%+#$ Polio dan
H!'a"i"i# A
8
K+li"
L+2a %in.an
T+#+2an
Gi.i"an
Pa'o0a0i%+#
H!%'!#0i%+#
Po0i%+#H!%'!# 0i%+#
H!'adna0i%+#
R!"%o0i%+#
Ra*do0i%+#
To.a0i%+#
Fla0i0i%+#
Pa'iloa0i%+#
H!%'!# Si'l!
Mol+#&+ &on"a.io#+$O%,
8
8
8
8
8
8
8
8
8E'#"!in Ba%%$ 1y"o!.alo0i%+#
H!'a"i"i# B
AIDS
Ra*i!#
Banya2 #'!#i!# EEE
Banya2 #'!#i!# d!a 2+nin.
8/9/2019 Patogenesis-2
12/37
UNTUK MENYEBABKAN PENYAKIT VIRUS HARUS :Ma#+2 R!'li2a#i '%i!% P!ny!*a%an Vi%+# 1!d!%a #!l R!#'on i+n Inan.
P!*!%#i/an Vi%+#5in,!2#i !n!"a' #!&a%a '!%#i#"!n P!l!'a#an Vi%+#
INFEKSI VIRUS :# Kon"a2 lan.#+n.# Kon"a2 "a2 lan.#+n.
BAGANPOLA PATOGENESIS POTENSIAL INFEKSI VIRUS
In,!2#i 0i%+# '%i!%
T!'a" lo2ali#a#i
Vi%+#
P!nya2i" 'd "!'a"
lo2ali#a#i5a#i'"oa"i2
P!ny!*a%an lan.#+n.
'd 9"a%.!" o%.an#N!%0+# '!%i,!%
Da%a/Si#"i li,a"i2Ta%.!" o%.an
Li'a
Ha"i
L!2o#i"P!nya2i"
P!nya2i"
Da%a/
8/9/2019 Patogenesis-2
13/37
PATOGENESIS
P!a#+2an ; R!'li2a#i P%i!%P!ny!*a%an 0i%+# ; "%o'i#! #!l
# 0i%+# !ny!*a*2an '!nya2i" 'ada "!'a" yan. 7a+/ da%i "!'a"
a#+2nya# 0i%+# !'+nyai "%o'i#! "!%/ada' 7a%in.an a"a+ #!l
R%S%&T'R2/+#+# di'!%+2aan #!l +n"+2 0i%+# (%!#!'"o%2o'on!n '!%+2aan yan. *!%in"!%a2#i #!&a%a 2/+#+# d!n.an
#+a"+ da!%a/ di'!%+2aan 0i%+# (2a'#id5#!l+*+n.) +n"+2
!+lai in,!2#i)
M!li*a"2an ENIM
8/9/2019 Patogenesis-2
14/37
1!d!%a #!l dan P!nya2i" 2lini2In,!2#i 0i%+# 2!%+#a2an #!l57a%in.an$ i#alnya : /ilan.nya
'%od+2#i /o%onE'i"!l +#+# &!'a" %!.!n!%a#i
O"a2 la*a" %!.!n!%a#i
P!ny!*+/an
a2i2a" in,!2#i 0i%+# *i#a "!%7adi 2!a"ian a"a+ #!*+/ !li*a"2ani+ni"a# /+o%al *!%'!%an"a%a #!l$ in"!%,!%on$ li,o2in dan ,a2"o%
'!%"a/anan lain
P!l!'a#an 0i%+#*anya2 "!%7adi 'ada "!'a" a#+2 0i%+#
Vi%+# Ra*i!# "ida2 !n.alai '!l!'a#an ,a"al
8/9/2019 Patogenesis-2
15/37
KEMUNGKINAN YANG DAPAT TER6ADI PADA INTERAKSI VIRUS < HOSPES
#Resistentak terlihat terjadi adanya hubungan
#Infeksi Subklinik&enyembuhan Infeksi &ersisten
#&enyakit (kut!KlinikKematian
Sembuh dengan!Tanpa se)uele
Sembuh dengan Infeksi *atent!&ersisten
#Infeksi +enahun Khronik"(simptomatik, *atent
*atent dengan Rekurensi
&ersisten dengan &enyakit Khronik
nfeksi Virus *ambat Slo Virus Infetion"
#Transformasi +alignan
#Virus bertindak sebagai .Triger/Reaksi 0ospes tak normal Sindrom
Reye, Sindrom 1remik 0emolitik
8/9/2019 Patogenesis-2
16/37
%ourse of Viral Infection
#rimary Replication
! The place of primary replication is where the virus replicates after
gaining initial entry into the host.
! This frequently determines whether the infection will be locali=ed atthe site of entry or spread to become a systemic infection.
Systemic Spread
! *part from direct celltocell contact' the virus may spread
via the blood stream and the %7$.
Secondary Replication
! $econdary replication takes place at susceptible organs4tissues
following systemic spread.
8/9/2019 Patogenesis-2
17/37
%ell Tropism
Viral affinity for specific body tissues 2tropism3 is
determined by
! %ell receptors for virus.
! %ell transcription factors that recogni=e viralpromoters and enhancer sequences.
! *bility of the cell to support virus replication.
! Physical barriers.
! ,ocal temperature' p+' and o-ygen tensionen=ymes and nonspecific factors in bodysecretions.
! #igestive en=ymes and bile in the gastrointestinaltract that may inactivate some viruses.
8/9/2019 Patogenesis-2
18/37
%ell #amage
Viruses may replicate widely throughout the body without
any disease symptoms if they do not cause significant cell
damage or death.
"etroviruses do not generally cause cell death' being
released from the cell by budding rather than by cell lysis'
and cause persistent infections.
%onversely' Picornaviruses cause lysis and death of the
cells in which they replicate' leading to fever and increasedmucus secretion in the case of "hinoviruses' paralysis or
death 2usually due to respiratory failure3 for Poliovirus.
8/9/2019 Patogenesis-2
19/37
Immune "esponse
The immune response to the virus probably has the greatest impact
on the outcome of infection.
In the most cases' the virus is cleared completely from the body
and results in complete recovery.
In other infections' the immune response is unable to clear the
virus completely and the virus persists.
In a number of infections' the immune response plays a major
pathological role in the disease.
In general' cellular immunity plays the major role in clearing virus
infection whereas humoral immunity protects against reinfection.
8/9/2019 Patogenesis-2
20/37
Immune Pathological "esponse
(nhanced viral injury could be due to one or a mi-ture of
the following mechanisms:
! Increased secondary response to Tc cells e.g. +)V! $pecific *#%% or complement mediated cell lysis
! )inding of unneutrali=ed virus*b comple-es to cell
surface 1c receptors' and thus increasing the number
of cells infected e.g. #engue haemorrhagic fever' +IV.
! Immune comple- deposition in organs such as the
skin' brain or kidney e.g. rash of rubella and measles.
8/9/2019 Patogenesis-2
21/37
Viral %learance or Persistence
The majority of viral infections are cleared but certain
viruses may cause persistent infections. There are 8
types of chronic persistent infections.
True ,atency the virus remains completely latent
following primary infection e.g. +$V' V>V. Its
genome may be integrated into the cellular genome or
e-ists as episomes.
Persistence the virus replicates continuously in the
body at a very low level e.g. +IV' +)V' %&V' ()V.
8/9/2019 Patogenesis-2
22/37
&echanisms of Viral Persistence
! antigenic variation
! immune tolerance' causing a reduced response to an antigen' may be dueto genetic factors' prenatal infection' molecular mimicry
! restricted gene e-pression
! downregulation of &+% class I e-pression' resulting in lack ofrecognition of infected cells e.g. *denoviruses
! downregulation of accessory molecules involved in immune recognitione.g. ,1*5 and I%*&/ by ()V.
! infection of immunopriviliged sites within the body e.g. +$V in sensoryganglia in the %7$
! direct infection of the cells of the immune system itself e.g. +erpesviruses' "etroviruses 2+IV3 often resulting in immunosuppression.
8/9/2019 Patogenesis-2
23/37
(-amples of Viral Pathogenesis
8/9/2019 Patogenesis-2
24/37
+erpes $imple- Virus
+$V is spread by contact' as the virus is shed in saliva' tears' genital
and other secretions.
Primary infection is usually trivial or subclinical in most individuals.
It is a disease mainly of very young children ie. those below ? years.
*bout /@A of the population acquires +$V infection through the
genital route and the risk is concentrated in young adulthood.
1ollowing primary infection' B?A of orally infected individuals and
C@A of patients with genital herpes will e-perience recurrences. The actual frequency of recurrences varies widely between
individuals. The mean number of episodes per year is about /.C.
8/9/2019 Patogenesis-2
25/37
Pathogenesis
#uring the primary infection' +$V spreads locally and a shortlived
viraemia occurs' whereby the virus is disseminated in the body. $pread to
the to craniospinal ganglia occurs.
The virus then establishes latency in the craniospinal ganglia.
The e-act mechanism of latency is not known' it may be true latency
where there is no viral replication or viral persistence where there is a low
level of viral replication.
"eactivation * It is well known that many triggers can provoke arecurrence. These include physical or psychological stress' infection:
especially pneumococcal and meningococcal' fever' irradiation: including
sunlight' and menstruation.
8/9/2019 Patogenesis-2
26/37
AKTIVASI PERIODIK INFEKSI VIRUS HERPES SIMPLE=
> ? @ 3
A
B
1
D
E
F
G
H
I
6
Ga%i# a*an.In,!2#i ini"ial
S"i+l+#
A 8 6 In,!2#i %!2+%!n
> In,!2#i #+*2lini2 (ina''a%!n") &o0!%"
? In,!2#i 2lini2 (a''a%!n") o0!%"
@ In,!2#i la"!n"
3 In,!2#i 2lini2
In,!2#i la"!n"
8/9/2019 Patogenesis-2
27/37
%linical &anifestations
+$V is involved in a variety of clinical manifestations
which includes :
/. *cute gingivostomatitis
8. +erpes ,abialis 2cold sore3
5. cular +erpes
B. +erpes ;enitalis
?. ther forms of cutaneous herpesD. &eningitis
0. (ncephalitis
E. 7eonatal herpes
8/9/2019 Patogenesis-2
28/37
GAMBARAN PENYAKIT VIRUS AKUT
INFEKSI LOKAL INFEKSI SISTEMIK
2ontoh penyakitspesifik
&ernapasan Rinovirus" 2ampak
Tempat patologi &intu masukTempat yangberdekatan
*ama inkubasi Relatif pendek Relatif panjang
Viremia Tidak ada (da
*ama imunitas
3ervariasi, mungkin
pendek 3iasanya umur panjang
(b sekretor Ig(" padaresistensi
penting Tidak penting
8/9/2019 Patogenesis-2
29/37
VIRUS ONKOGENIK
VIRUS DNA :
PAPOVAVIRIDAEVi%+# PolyoaSiian Vi%+# 34 (SV 34)Vi%+# Pa'iloa K!lin&iVi%+# Pa'iloa Bo0in
HERPESVIRIDAEVi%+# P!nya2i" Ma%!2Vi%+# Ka%#inoa Kodo2 L+&2!H!%'!#0i%+# Saii%iVi%+# E'#"!in 8 Ba%%Vi%+# H!%'!# Si'l!
HEPADNAVIRIDAEVi%+# H!'a"i"i# B
PO=VIRIDAEVi%+# YABAVi%+# Fi*%oa K!lin&i
VIRUS RNA :
RETROVIRIDAEVi%+# L!+2!ia M+%inVi%+# F%i!ndVi%+# Maldn!yVi%+# Ra+#&/!%Vi%+# G%o##
Vi%+# T+o% Maa!Vi%+# AIDS (HTLV III5 LAV$ HIV)
( H+an T
8/9/2019 Patogenesis-2
30/37
VIRUS DENGAN REAKSI HOSPES YANG LUAR BIASA
Sind%o R!y! :Vi%+# In,l+!n-aVi%+# Va%i&!lla 8 oo#"!%Vi%+# Pa%ain,l+!n-aP!nya2i" Vi%+# P%odoal yan. "a2 "!%id!n"i,i2a#i R!o0i%+#$ E&/o0i%+#
1o#a&2i!0i%+#$ Ad!no0i%+#$ H!%'!#0i%+#
SINDROM HEMOLITIK :1o#a&2i!0i%+#
Vi%+# 6aninVi%+# E'#"!in 8 Ba%%P!nya2i" Vi%+# P%odoal yan. "a2 "!%id!n"i,i2a#i
8/9/2019 Patogenesis-2
31/37
Sind%o G+illain 8 Ba%%! : Vi%+# E'#"!in 8 Ba%%
Vi%+# 0a2#in In,l+!n-a Ba*i Vi%+# Pa%o"i"i# E'id!i&a
En&!,alo'a"i Pa#&a In,!2#i : Vi%+# Mo%*ili Vi%+# Va&&inia Vi%+# Va%i&!lla 8 oo#"!% Vi%+# 'a%o"i"i# E'id!i&a
Mo%*ili A"i'i2 :Vi%+# Mo%*ili 'ada o%an. yan. dii+ni#a#i d!n.an
Vi%+# 0a2#in Mo%*ili yan. dia"i2an
8/9/2019 Patogenesis-2
32/37
BAGAN INFEKSI AKUT DAN MA1AM
8/9/2019 Patogenesis-2
33/37
INFEKSI VIRUS PADA SALURAN PERNAPASAN
Vi%+# P!ny!*a* yan. Palin. S!%in.
Sind%oa G!7ala U"aa Bayi Ana2
8/9/2019 Patogenesis-2
34/37
INFEKSI VIRUS PADA 6ANIN
Vi%+#
ani"a Hail yan. P!2a
A*o%"+#
S'on"an
6anin
No%al
In,!2#i
Anion
In,!2#i
Pla#!n"a
In,!2#i 6anin
In,!2#i Ma"!%nal
T!l+%
6anin
No%al
6anin T!%in,!2#i
(
'!nya2i")
K!a"ian 6anin
(A*o%"+#$ la/i% a"i)Mal,o%a#i
( a"i)
In"%a0
a.in
a Vi%!ia
8/9/2019 Patogenesis-2
35/37
INFEKSI VIRUS PERINATAL
K!#!%in.an a2"+ In,!2#i
Vi%+#P%!na"al
(dala +"!%+#)
Na"al
(S!laaP!%#alinan)
Po#"na"al
(S!"!la/P!%#alinan)
In#id!nN!ona"al ('!%
>444 la/i%/id+')
R+*!la 8 6a%an. 4$> 8 4$
1y"o!.alo0i%+# < ?
H!%'!# Si'l! 4$4@ 8 4$
Va%i&!lla
8/9/2019 Patogenesis-2
36/37
RESPON IMUN TERHADAP BERBAGAI INFEKSI VIRUS
In"!%,!%on dan I.A P!%"a/anan +"aa 'ada !'i"!l
'!%+2aan
Vi%!ia Vi%+# %!n"an "!%/ada' An"i*odi
Vi%+# di dala #!l Si#"i i+n /+o%al
Si#"i i+n #!l+l!%
An"i*odi !lal+i AD11
P!n./an&+%an 0i%+# di dala #!l M!n.+n"+n.2an
I+no'a"olo.i2
8/9/2019 Patogenesis-2
37/37
$ummary
Viral Pathogenesis depends on the comple- interplay of a
large number of viral and host factors.
Viral factors include cell tropism and cellularpathogenesis.
The immune response is the most important host factor' as
it determines whether the virus is cleared or not.
$ometimes' the immune response itself is responsible for
the damage.